DRKS00015832招募中不适用
Characterization of the impact of a polyacrylate-containing wound dressing (HydroClean®) on wound healing in chronic and acute wounds through analysis of wound exudate - HydroClean extension
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Part A, chronic venous leg ulcer:
- •Patient is 18 years of age or older and has given formal written consent.
- •Patient suffers from Ulcus cruris venosum (positive venous reflux testing, e.g. ultrasound).
- •Target ulcer size is between 5cm2 and 50cm2.
- •Target ulcer persists since min. 3 and max. 36 months
- •Wound surface is covered with yellow fibrin deposits by 40% or more. Wound is in need for cleansing/wound bed preparation.
- •Ankle-brachial pressure index (ABPI) is between 0.8 and 1.05
- •Patient is suitable for and agrees to use compression therapy (PütterPro2) for the study duration and was using compression therapy before study inclusion.
- •Patient is able to walk in conjunction to compression therapy. Ankle mobility is fully mobile to limited mobile.
- •Part B, acute wounds:
- •Patient is 18 years of age or older and has given formal written consent.
- •Patient underwent a split-thickness skin harvesting procedure within the last 24 h and needs dressing for the donor site wound.
- •Split-thickness donor site wound size is between 5cm2 and 50cm2.
排除标准
- •Part A, chronic wounds:
- •Known allergies/hypersensitivity or intolerance to any of the study product ingredients.
- •According to physician’s assessment, the patient is not able to follow the study protocol (e.g. due to cognitive disease) or is not able to understand state, nature, meaning and consequences of the study.
- •According to physician’s assessment, the patient’s general condition does not allow participation or makes it unlikely to take part in the study for the treatment period of 12 weeks.
- •Patients with hypertensive leg ulcers (Ulcus cruris hypertonicum Martorell).
- •Patient suffers from septic phlebitis, severe deep vein thrombosis (phlegmasia cerulea dolens) or other conditions posing a contraindication for compression therapy according to established guidelines and local procedures (e.g. significant sensory neuropathy).
- •Patient suffers from decompensated heart insufficiency (NYHA Class IV, ACC.AHA Stage D).
- •Patient suffers from poorly controlled diabetes mellitus (HbA1c <70 mmol/mol; < 8.6%).
- •Patient suffers from severe dysfunction of liver or kidney (e.g. clinically relevant liver fibrosis, cirrhosis, prolonged prothrombin time, decreased albumin levels) and/ or kidney disease (e.g. clinically relevant increase in serum creatinine, significant proteinuria, requirement for hemodialysis).
- •Patient suffers from significant malnutrition with reduced serum albumin levels.
- •Patient suffers from active autoimmune disease requiring corticosteroid treatment (> 10 mg prednisolone equivalent/day) and/or other immunosuppressive and/ or chemotherapy.
- •Wound is caused by malign tumor (primary or metastasis).
- •In addition to study product, further products in direct contact to wound surface will be used.
- •The target ulcer was treated with HydroClean® during the last four weeks before study start.
- •Participation in this study or any other study in the last four weeks before beginning of this study.
- •Female patients of childbearing age, pregnancy (suspected or confirmed), or breast-feeding women
- •Part B, acute wounds:
- •Known allergies/hypersensitivity or intolerance to any of the study product ingredients.
- •According to physician’s assessment, the patient is not able to follow the study protocol (e.g. due to cognitive disease) or is not able to understand state, nature, meaning and consequences of the study.
- •Coagulation disorders
- •Active wound infection treated with systemic antibiotics
- •Patient suffers from significant malnutrition with reduced serum albumin levels
- •Patient suffers from active autoimmune disease requiring corticosteroid treatment (> 10 mg prednisolone equivalent/day) and/or other immunosuppressive and/ or chemotherapy.
- •Patient suffers from severe dysfunction of liver or kidney (e.g. clinically relevant liver fibrosis, cirrhosis, prolonged prothrombin time, decreased albumin levels) and/ or kidney disease (e.g. clinically relevant increase in serum creatinine, significant proteinuria, requirement for hemodialysis).
- •Female patients of childbearing age, pregnancy (suspected or confirmed), or breast-feeding women
研究者
相似试验
招募中
3 期
Comparison of the effectiveness of Cyanoacrylate with Dentin bonding on the Rate of Changes in Tooth SensitivityDental Sensitivity.Other specified diseases of hard tissues of teethK03.89IRCT20120220009088N4Islamic Azad University40
招募中
Unknown
Investigating the effect of PMMA on the outcome of proximal humerus type 3 and 4 fracturesIRCT20230417057939N1Arak University of Medical Sciences60
尚未招募
4 期
Comparison of effects of two different designs of functional removable appliances on mandibular anterior teeth inclination in growing patients with underdeveloped mandible.CTRI/2024/01/061794Dr Suvin Chaudhary
招募中
不适用
Surgical glue for the treatment of damaged veins in patients with venous leg ulcersVenous leg ulcerInjury, Occupational Diseases, PoisoningISRCTN15014758niversity Hospital of South Manchester55
招募中
Unknown
PAA-PVP trialJPRN-jRCTs032220597Yamamoto Suguru50